ROCK1 and Parkinson disease: In the nervous system, ROCK1 pharmacological inhibition resulted in prevention of fostered axonal regeneration, beneficially regulated microglial dysfunction, and ameliorated neurodegeneration in models of PD and other neurodegenerative disorders (Borrajo, Rodriguez‐Perez, Villar‐Cheda, Guerra, & Labandeira‐Garcia, 2014).